Assertio begins tender offers for convertible notes due 2021, 2024

By Marisa Wong

Los Angeles, March 11 – Assertio Therapeutics, Inc. said it has begun cash tender offers to purchase any and all of the outstanding $42,465,000 of its 2.5% senior convertible notes due 2021 (Cusip: 249908AA2) and $34,522,000 of its 5% senior convertible notes due 2024 (Cusip: 04545LAA5).

The offers are set to expire at 11:59 p.m. ET on April 7.

Holders who tender their notes at or prior to the expiration time will be entitled to receive in cash $995 per $1,000 principal amount of notes plus accrued interest up to but excluding the settlement date.

The company said it will fund any purchases of notes under the offers from available cash on hand.

The offers are not conditioned on any minimum number of notes being tendered but are subject to various other conditions.

Tenders may be withdrawn prior the expiration of the offers.

SunTrust Robinson Humphrey, Inc. (404 926-5675) is dealer manager for the offers.

Global Bondholder Services Corp. (866 807-2200 or contact@gbsc-usa.com) is the information and tender agent.

Assertio is a Lake Forest, Ill.-based pharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.